Consequences of avoiding β-lactams in patients with β-lactam allergies

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 4, 2016, Pages 1148-1153

  Jeffres, Meghan N ^a   Narayanan, Prasanna P ^b   Shuster, Jerrica E ^c   Schramm, Garrett E ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b MAYO CLINIC   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

Author keywords

bloodstream infection; empiric antibiotic; gram negative; penicillin allergy; Lactam allergy

Indexed keywords

CARBAPENEM; CEFEPIME; CEPHALOSPORIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; BETA LACTAM;

ADULT; ALLERGIC REACTION; ANAPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; CARBAPENEM ALLERGY; CEPHALOSPORIN ALLERGY; DRUG HYPERSENSITIVITY; FEMALE; GRAM NEGATIVE BACILLI BLOODSTREAM INFECTION; HOSPITAL MORTALITY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PENICILLIN ALLERGY; PERSONAL EXPERIENCE; PREVALENCE; PRIORITY JOURNAL; RASH; TEMPERATURE; UNIVERSITY HOSPITAL; ADOLESCENT; AGED; BACTERIAL INFECTIONS; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TREATMENT FAILURE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMS; DRUG HYPERSENSITIVITY; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; YOUNG ADULT;

EID: 84950112684     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.10.026     Document Type: Article

References (37)

1. C.E. Lee, T.R. Zembower, M.A. Fotis, M.J. Postelnick, P.A. Greenberger, L.R. Peterson, and et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance Arch Intern Med 160 2000 2819 2822
2. M.J. Hall, S.N. Williams, C.J. DeFrances, and A. Golosinskiy Inpatient care for septicemia or sepsis: a challenge for patients and hospitals NCHS Data Brief 62 2011 1 8
3. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, S.M. Opal, and et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 Crit Care Med 41 2013 580 637
4. A.R. Tunkel, B.J. Hartman, S.L. Kaplan, B.A. Kaufman, K.L. Roos, W.M. Scheld, and et al. Practice guidelines for the management of bacterial meningitis Clin Infect Dis 39 2004 1267 1284
5. J.S. Solomkin, J.E. Mazuski, J.S. Bradley, K.A. Rodvold, E.J. Goldstein, E.J. Baron, and et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Clin Infect Dis 50 2010 133 164
6. American Thoracic Society; Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 2005 388 416
7. B.A. Lipsky, A.R. Berendt, P.B. Cornia, J.C. Pile, E.J. Peters, D.G. Armstrong, and et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections Clin Infect Dis 54 2012 e132 e173
8. D.L. Stevens, A.L. Bisno, H.F. Chambers, E.P. Dellinger, E.J. Goldstein, S.L. Gorbach, and et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America Clin Infect Dis 59 2014 e10 52
9. Drug allergy: an updated practice parameter Ann Allergy Asthma Immunol 105 2010 259 273
10. D.F. Gaieski, M.E. Mikkelsen, R.A. Band, J.M. Pines, R. Massone, F.F. Furia, and et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department Crit Care Med 38 2010 1045 1053
11. A. Kumar, D. Roberts, K.E. Wood, B. Light, J.E. Parrillo, S. Sharma, and et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 2006 1589 1596
12. M. Morrell, V.J. Fraser, and M.H. Kollef Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality Antimicrob Agents Chemother 49 2005 3640 3645
13. A. Buonomo, E. Nucera, T. De Pasquale, V. Pecora, C. Lombardo, V. Sabato, and et al. Tolerability of aztreonam in patients with cell-mediated allergy to β-lactams Int Arch Allergy Immunol 155 2011 155 159
14. G. Patriarca, D. Schiavino, C. Lombardo, G. Altomonte, M. De Cinti, A. Buonomo, and et al. Tolerability of aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams Int J Immunopathol Pharmacol 21 2008 375 379
15. P.R. Rhomberg, and R.N. Jones Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005) Diagn Microbiol Infect Dis 57 2007 207 215
16. J. Garnacho-Montero, J.L. Garcia-Garmendia, A. Barrero-Almodovar, F.J. Jimenez-Jimenez, C. Perez-Paredes, and C. Ortiz-Leyba Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis Crit Care Med 31 2003 2742 2751
17. C.I. Kang, S.H. Kim, W.B. Park, K.D. Lee, H.B. Kim, E.C. Kim, and et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome Antimicrob Agents Chemother 49 2005 760 766
18. A. Labelle, P. Juang, R. Reichley, S. Micek, J. Hoffmann, A. Hoban, and et al. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment∗ Crit Care Med 40 2012 2016 2021
19. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
20. A. Geddes, M. Thaler, S. Schonwald, M. Harkonen, F. Jacobs, and I. Nowotny Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial J Antimicrob Chemother 44 1999 799 810
21. D. Gardiner, G. Dukart, A. Cooper, and T. Babinchak Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials Clin Infect Dis 50 2010 229 238
22. M. West, B.R. Boulanger, C. Fogarty, A. Tennenberg, B. Wiesinger, M. Oross, and et al. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study Clin Ther 25 2003 485 506
23. A. Torres, T.T. Bauer, C. Leon-Gil, F. Castillo, F. Alvarez-Lerma, A. Martínez-Pellús, and et al. Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 55 2000 1033 1039
24. A.T. Freire, V. Melnyk, M.J. Kim, O. Datsenko, O. Dzyublik, F. Glumcher, and et al. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia Diagn Microbiol Infect Dis 68 2010 140 151
25. S. Towfigh, J. Pasternak, A. Poirier, H. Leister, and T. Babinchak A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections Clin Microbiol Infect 16 2010 1274 1281
26. Z. Chen, J. Wu, Y. Zhang, J. Wei, X. Leng, J. Bi, and et al. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial BMC Infect Dis 10 2010 217
27. M.A. Malangoni, J. Song, J. Herrington, S. Choudhri, and P. Pertel Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections Ann Surg 244 2006 204 211
28. E. Macy, and R. Contreras Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: a cohort study J Allergy Clin Immunol 133 2014 790 796
29. M. Picard, P. Bégin, H. Bouchard, J. Cloutier, J. Lacombe-Barrios, J. Paradis, and et al. Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital J Allergy Clin Immunol Pract 1 2013 252 257
30. M. Li, M.T. Krishna, S. Razaq, and D. Pillay A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of 'penicillin allergy' in a UK teaching hospital J Clin Pathol 67 2014 1088 1092
31. J.C. Caubet, L. Kaiser, B. Lemaitre, B. Fellay, A. Gervaix, and P.A. Eigenmann The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge J Allergy Clin Immunol 127 2011 218 222
32. M.E. Pichichero, and J.R. Casey Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis Otolaryngol Head Neck Surg 136 2007 340 347
33. A.J. Apter, J.L. Kinman, W.B. Bilker, M. Herlim, D.J. Margolis, E. Lautenbach, and et al. Is there cross-reactivity between penicillins and cephalosporins? Am J Med 119 2006 354.e11 354.e119
34. A. Romano, R.M. Gueant-Rodriguez, M. Viola, R. Pettinato, and J.L. Gueant Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins Ann Intern Med 141 2004 16 22
35. M. Atanaskovic-Markovic, F. Gaeta, M. Gavrovic-Jankulovic, T.C. Velickovic, R.L. Valluzzi, and A. Romano Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillins J Allergy Clin Immunol 124 2009 167 169
36. B. Kula, G. Djordjevic, and J.L. Robinson A systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins? Clin Infect Dis 59 2014 1113 1122
37. L. Ma, T.M. Danoff, and L. Borish Case fatality and population mortality associated with anaphylaxis in the United States J Allergy Clin Immunol 133 2014 1075 1083